Publications
Export 19 results:
Filters: Author is Roberge, Pasquale [Clear All Filters]
“An analysis of differential improvement by diagnosis in group transdiagnostic cognitive behaviour therapy for anxiety disorders.”, J Ment Health, vol. 32, no. 3, pp. 619-624, 2023.
“Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.”, Can J Psychiatry, p. 7067437231187459, 2023.
“Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data.”, Psychol Med, pp. 1-13, 2023.
“An examination of sudden gain prevalence across cognitive-behavioural therapy for anxiety and depressive disorders: A quantitative analysis and meta-analytic review.”, J Anxiety Disord, vol. 95, p. 102697, 2023.
“Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework.”, BMC Health Serv Res, vol. 23, no. 1, p. 596, 2023.
“French adaptation and validation of the Panic Disorder Severity Scale-self-report.”, BMC Psychiatry, vol. 22, no. 1, p. 434, 2022.
“A pragmatic randomized controlled trial of a group self-management support program versus treatment-as-usual for anxiety disorders: study protocol.”, BMC Psychiatry, vol. 22, no. 1, p. 135, 2022.
“Which, who and when? Therapeutic processes in group cognitive behaviour therapy for anxiety disorders.”, Clin Psychol Psychother, vol. 29, no. 5, pp. 1742-1754, 2022.
, “Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.”, Psychol Med, pp. 1-11, 2020.
, “Getting better my way: Feasibility study of a self-management support tool for people with mood and anxiety disorders.”, Psychiatr Rehabil J, 2018.
, “A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.”, BMC Psychiatry, vol. 18, no. 1, p. 320, 2018.
, “[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].”, Sante Ment Que, vol. 42, no. 1, pp. 85-103, 2017.
, “Profiles of Recovery from Mood and Anxiety Disorders: A Person-Centered Exploration of People's Engagement in Self-Management.”, Front Psychol, vol. 7, p. 584, 2016.
, “Mental health self-management questionnaire: Development and psychometric properties.”, J Affect Disord, vol. 181, pp. 41-9, 2015.
, “A provincial adaptation of clinical practice guidelines for depression in primary care: a case illustration of the ADAPTE method.”, J Eval Clin Pract, vol. 21, no. 6, pp. 1190-8, 2015.
, “Self-Management Strategies in Recovery From Mood and Anxiety Disorders.”, Glob Qual Nurs Res, vol. 2, p. 2333393615606092, 2015.
, “Benzodiazepine and dementia: a time for reflection.”, Maturitas, vol. 75, no. 2, pp. 105-6, 2013.
, “[Mental Health Action Plan: contextual analysis and elements impacting on organization of primary care services and collaborative issues].”, Sante Ment Que, vol. 34, no. 1, pp. 35-53, 2009.
